23 results
8-K
EX-99.1
BEAM
Beam Therapeutics Inc
8 Jan 24
Results of Operations and Financial Condition
6:55am
BEAM-301 Potential: Correct liver G6PC mutation to restore enzyme activity and enable normal glucose homeostasis, as well as eliminate chronic
8-K
EX-99.1
poqh15ji
7 Nov 22
Beam Therapeutics Announces Portfolio Progress and Reports Third Quarter 2022 Financial Results
7:00am
8-K
EX-99.1
km0py7f2urlsvw 9t7
10 Jan 22
Results of Operations and Financial Condition
6:45am
8-K
EX-99.1
t94k0nh nwm
8 Nov 21
Beam Therapeutics Provides Business and Pipeline Updates and Reports Third Quarter 2021 Financial Results
6:19am
10-K
l9k23sqdzrazdq
30 Mar 20
Annual report
5:26pm
424B4
zje2dwb2pyz41ub3mkq
7 Feb 20
Prospectus supplement with pricing info
12:00am
S-1/A
s075bpt
17 Jan 20
IPO registration (amended)
4:09pm